Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Goodwill & Intangibles (2016 - 2021)

Historic Goodwill & Intangibles for Capricor Therapeutics (CAPR) over the last 11 years, with Q1 2021 value amounting to $1083.0.

  • Capricor Therapeutics' Goodwill & Intangibles fell 7999.26% to $1083.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $1083.0, marking a year-over-year decrease of 7999.26%. This contributed to the annual value of $2165.0 for FY2020, which is 6666.67% down from last year.
  • Capricor Therapeutics' Goodwill & Intangibles amounted to $1083.0 in Q1 2021, which was down 7999.26% from $2165.0 recorded in Q4 2020.
  • In the past 5 years, Capricor Therapeutics' Goodwill & Intangibles registered a high of $130066.0 during Q1 2017, and its lowest value of $1083.0 during Q1 2021.
  • Its 5-year average for Goodwill & Intangibles is $48107.1, with a median of $38952.0 in 2019.
  • The largest annual percentage gain for Capricor Therapeutics' Goodwill & Intangibles in the last 5 years was 3458.98% (2017), contrasted with its biggest fall of 9295.39% (2017).
  • Capricor Therapeutics' Goodwill & Intangibles (Quarter) stood at $93048.0 in 2017, then tumbled by 46.51% to $49772.0 in 2018, then crashed by 86.95% to $6495.0 in 2019, then plummeted by 66.67% to $2165.0 in 2020, then plummeted by 49.98% to $1083.0 in 2021.
  • Its Goodwill & Intangibles stands at $1083.0 for Q1 2021, versus $2165.0 for Q4 2020 and $3248.0 for Q3 2020.